Topical treatment of interdigital tinea pedis, tinea cruris and tinea corporis.
- Inhibits an enzyme necessary for ergosterol synthesis, required for fungal cell membranes.
- Antifungal action .
Resolution of dermal fungal infection.Spectrum:
Active against Trichyphyton rubrum and Epidermpophyton floccosum.
Absorption: Small amounts are systemically absorbed.
Protein Binding: >99%
Metabolism and Excretion: Unknown.
TIME/ACTION PROFILE (improvement/resolution of infection)
- None noted.
Use Cautiously in:
- OB: Lactation:Safety not established;
- Pedi: Safety and effectiveness not established.
Adverse Reactions/Side Effects
Derm: application site reactions
* CAPITALS indicate life-threatening.
Underline indicate most frequent.
May inhibit the activity of the CYP2C19 enzymes.
Topical: (Adults) Interdigital tinea pedis Apply to affected and surrounding areas once daily for two weeks; Tinea cruris and tinea corporis Apply to affected and surrounding areas once daily for one week.
- Inspect involved areas of skin and mucous membranes before and frequently during therapy. Increased skin irritation may indicate need to discontinue medication.
- Consult health care professional for proper cleansing technique before applying medication.
- Topical: For Interdigital tinea pedis: Apply thin layer to cover affected area and approximately 1 inch of immediate surrounding area completely daily for 2 wk.
- For Tinea Cruris or Tinea Corporis: Apply thin layer to affected area and approximately 1 inch of immediate surrounding area daily for 1 wk.
- Avoid the use of occlusive wrappings or dressings unless directed by health care professional. Wash hands after application.
- Instruct patient to apply medication as directed for full course of therapy, even if feeling better. Emphasize the importance of avoiding the eyes and vagina.
- Patients with athlete's foot should be taught to wear well-fitting, ventilated shoes, to wash affected areas thoroughly, and to change shoes and socks at least once a day.
- Advise patient to report increased skin irritation or lack of response to therapy to health care professional.
- Instruct patient to notify health care professional of all Rx or OTC medications, vitamins, or herbal products being taken and consult health care professional before taking any new medications.
- Advise female patient to notify health care professional if pregnancy is planned or suspected or if breastfeeding.
Decrease in skin irritation and resolution of infection.
Anesthesia Central is an all-in-one web and mobile solution for treating patients before, during, and after surgery. This collection of drug, procedures and test information is derived from Davis’s Drug, MGH Clinical Anesthesia Procedures, Pocket Guide to Diagnostic Tests, and MEDLINE Journals. Learn more.